Bard Associates’s Cigna CI Stock Holding History

Bard Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11	Closed	-$2.94K	–	305
2026 Q1	$2.94K	Buy	+11	New	+$3.04K	﹤0.01%	256

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Bard Associates's CI Position: Q2 2026 in Review

Bard Associates sold out of Cigna (CI) in Q2 2026, closing a stake of 11 shares — an estimated $2.94K sold.

Bard Associates first reported a position in CI in Q1 2026 and held it in 1 quarter. The position peaked at $2.94K in Q1 2026. 1,695 funds tracked by Wall St. Rank hold CI as of Q2 2026.

Bard Associates reported no remaining Cigna position as of Q2 2026 after selling out during the quarter.
Bard Associates sold 11 Cigna shares in Q2 2026, an estimated $2.94K.
Bard Associates first reported a position in Cigna in Q1 2026 and held it in 1 quarter.
Bard Associates's Cigna position peaked at $2.94K in Q1 2026.
1,695 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.